Articles & Resources

Ozempic Onset Timeline: When To Expect Weight Loss & Results

How long Ozempic takes to work: the 0.25 mg starting month, when appetite and blood sugar change, why weight change is gradual and what to track.

What to look for in a calorie counting app on a GLP-1 medication: fast logging, protein and water, plus a place for doses and side effects.

What a food tracker should do for someone on a GLP-1 medication: log protein, fiber and fluids, and keep doses and side effects alongside meals.

A plain guide to the GLP-1 medicines approved for weight management, how their dosing steps work, and what to track while you take them.

What Zepbound (tirzepatide) is, who it is approved for, how it is dosed, and the main safety warnings, based on the FDA prescribing information.

Semaglutide is the ingredient in Ozempic, Wegovy and Rybelsus. See which brand is approved for what, label dosing, trial results and side effects.

The Zepbound dosing schedule from the FDA label: 2.5 mg start, 2.5 mg steps every 4 weeks, 5-15 mg maintenance, and what to do about a missed dose.

How to get the most from a GLP-1 medication: take it as prescribed, log doses, protein, fluids and symptoms, and keep up diet and activity.

How GLP-1 weight loss injections work, which ones are approved for weight management, their dosing schedules, side effects and what to track.

Rybelsus is a daily semaglutide tablet for type 2 diabetes. See how it works, the label's dosing steps, common side effects and what to track.

Trulicity (dulaglutide) is a weekly injection for type 2 diabetes, not weight loss. Learn the label's dosing, side effects and what to track.

The most common GLP-1 side effects are digestive. See label rates, ways to ease nausea, and the warning signs that need a prescriber.

How GLP-1 medicines support weight loss, which ones are approved for it, what trials show, and what to track while you take them.

Ozempic is approved for type 2 diabetes, not weight loss. How it works, the dosing steps, Wegovy's trial results, side effects and what to track.

How prescription weight loss pills compare with GLP-1 injections: what each is approved for, how it is dosed, and what the labels say about risks.

Retatrutide is an investigational triple-agonist injection, not approved anywhere. What phase 2 and phase 3 trials report, and what is still unknown.

Saxenda (liraglutide 3 mg) is a daily injection for weight management. See who it is for, the label's dose steps, side effects and how it differs.

Tirzepatide activates GIP and GLP-1 receptors. See what Zepbound and Mounjaro are approved for, label dosing, trial results and side effects.

Zepbound (tirzepatide) vs Wegovy (semaglutide): approved uses, dosing, head-to-head trial results, and side effects, from the FDA labels.

The Wegovy pill is a daily oral semaglutide for adult weight management. See the label's dose steps, how to take it, trial results and side effects.

Mounjaro (tirzepatide) vs Ozempic (semaglutide): approved uses, dosing, head-to-head trial results, side effects, and how to track either one.

Ozempic and Wegovy both contain semaglutide. Compare approved uses, doses, dosing schedules and side effects, based on the FDA labels.

What Mounjaro (tirzepatide) is approved for, how its GIP and GLP-1 action works, the dosing schedule, and the side effects listed on its label.